Sales rise 25.29% to Rs 2217.42 crore
Net loss of Sun Pharmaceuticals Industries reported to Rs 906.42 crore in the quarter ended September 2018 as against net profit of Rs 577.05 crore during the previous quarter ended September 2017. Sales rose 25.29% to Rs 2217.42 crore in the quarter ended September 2018 as against Rs 1769.86 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales2217.421769.86 25 OPM %2.69-4.72 -PBDT441.23678.71 -35 PBT318.87573.63 -44 NP-906.42577.05 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content